81 related articles for article (PubMed ID: 2399491)
41. Enzyme-resistant CCK analogs with high affinities for central receptors.
Charpentier B; Durieux C; Pelaprat D; Dor A; Reibaud M; Blanchard JC; Roques BP
Peptides; 1988; 9(4):835-41. PubMed ID: 3226959
[TBL] [Abstract][Full Text] [Related]
42. Antidepressant-like effects of CCKB antagonists in mice: antagonism by naltrindole.
Derrien M; Durieux C; Roques BP
Br J Pharmacol; 1994 Mar; 111(3):956-60. PubMed ID: 8019773
[TBL] [Abstract][Full Text] [Related]
43. Effects of cholecystokinin octapeptide and BC 264, a potent and selective CCK-B agonist on aspartate and glutamate release from rat hippocampal slices.
Migaud M; Roques BP; Durieux C
Neuropharmacology; 1994 Jun; 33(6):737-43. PubMed ID: 7936111
[TBL] [Abstract][Full Text] [Related]
44. The selective CCK-B agonist, BC 264, impairs socially reinforced memory in the three-panel runway test in rats.
Derrien M; Daugé V; Blommaert A; Roques BP
Behav Brain Res; 1994 Dec; 65(2):139-46. PubMed ID: 7718145
[TBL] [Abstract][Full Text] [Related]
45. The behavioral effects of CCK8 injected into the medial nucleus accumbens are dependent on the motivational state of the rat.
Daugé V; Dor A; Féger J; Roques BP
Eur J Pharmacol; 1989 Apr; 163(1):25-32. PubMed ID: 2744093
[TBL] [Abstract][Full Text] [Related]
46. Excitatory effects of cholecystokinin in rat hippocampus: pharmacological response compatible with 'central'- or B-type CCK receptors.
Böhme GA; Stutzmann JM; Blanchard JC
Brain Res; 1988 Jun; 451(1-2):309-18. PubMed ID: 3251590
[TBL] [Abstract][Full Text] [Related]
47. Cholecystokinin modulates mesolimbic dopaminergic influences on male rat copulatory behavior.
Markowski VP; Hull EM
Brain Res; 1995 Nov; 699(2):266-74. PubMed ID: 8616630
[TBL] [Abstract][Full Text] [Related]
48. The stimulation of cholecystokinin receptors in the rostral nucleus accumbens significantly antagonizes the EEG and behavioural effects induced by phencyclidine in rats.
Popoli P; Reggio R; Pèzzola A; Scotti de Carolis A
Psychopharmacology (Berl); 1995 Jul; 120(2):156-61. PubMed ID: 7480547
[TBL] [Abstract][Full Text] [Related]
49. A cholecystokinin agonist/antagonist according to dose and time of action: effect on food intake.
Gourch A; Orosco M; Rodriguez M; Martinez J; Jacquot C; Cohen Y
Neuropeptides; 1990 Dec; 17(4):187-91. PubMed ID: 2093151
[TBL] [Abstract][Full Text] [Related]
50. Brain and gastrointestinal cholecystokinin receptor family: structure and functional expression.
Wank SA; Pisegna JR; de Weerth A
Proc Natl Acad Sci U S A; 1992 Sep; 89(18):8691-5. PubMed ID: 1528881
[TBL] [Abstract][Full Text] [Related]
51. Analogs of Ac-CCK-7 incorporating dipeptide mimics in place of Met28-Gly29.
Tilley JW; Danho W; Shiuey SJ; Kulesha I; Swistok J; Makofske R; Michalewsky J; Triscari J; Nelson D; Weatherford S
J Med Chem; 1992 Oct; 35(21):3774-83. PubMed ID: 1433191
[TBL] [Abstract][Full Text] [Related]
52. [N-methylnorleucine-(28,31)]cholecystokinin-(26-33) (SNF 8702) activity at a cloned rat CCKB receptor.
Knapp RJ; Malatynska E; Peterson P; Zalewska T; Fang S; Hruby VJ; Smith TL; Yamamura HI
Eur J Pharmacol; 1994 Oct; 269(2):133-8. PubMed ID: 7851490
[TBL] [Abstract][Full Text] [Related]
53. Bilateral midbrain transections block the behavioral effects of cholecystokinin on feeding and exploration in rats.
Crawley JN; Kiss JZ; Mezey E
Brain Res; 1984 Nov; 322(2):316-21. PubMed ID: 6509319
[TBL] [Abstract][Full Text] [Related]
54. Solution conformation of CCK9, a cholecystokinin analog.
Moroder L; D'Ursi A; Picone D; Amodeo P; Temussi PA
Biochem Biophys Res Commun; 1993 Feb; 190(3):741-6. PubMed ID: 8094956
[TBL] [Abstract][Full Text] [Related]
55. Evidence that type A CCK receptors facilitate dopamine efflux in rat brain.
Vickroy TW; Bianchi BR; Kerwin JF; Kopecka H; Nadzan AM
Eur J Pharmacol; 1988 Aug; 152(3):371-2. PubMed ID: 3220112
[No Abstract] [Full Text] [Related]
56. Effects of the novel cholecystokinin analogue Suc-Trp-N(Me)-Nle-Asp-Phe-NH2 on feeding and cortisol release in pigs.
Ebenezer IS; Parrott RF; Goode JA
Pharmacol Biochem Behav; 1996 May; 54(1):255-9. PubMed ID: 8728566
[TBL] [Abstract][Full Text] [Related]
57. Involvement of brain CCK in the adaptation of gut motility to digestive status and stress: a review.
Buéno L
J Physiol Paris; 1993; 87(5):301-6. PubMed ID: 8298607
[TBL] [Abstract][Full Text] [Related]
58. Benzodiazepines antagonize cholecystokinin-induced activation of rat hippocampal neurones.
Bradwejn J; de Montigny C
Nature; 1984 Nov 22-28; 312(5992):363-4. PubMed ID: 6095093
[TBL] [Abstract][Full Text] [Related]
59. Hyperlocomotion induced by dopamine or cholecystokinin + dopamine in the nucleus accumbens is not modified by chronic lithium treatment.
Zohar J; Murphy DL; Crawley JN
Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(5):775-9. PubMed ID: 2675195
[TBL] [Abstract][Full Text] [Related]
60. Evaluation of a series of novel CCKB antagonists using a functional assay in the rat central nervous system.
Boden PR; Pinnock RD; Pritchard MC; Woodruff GN
Br J Pharmacol; 1994 Jun; 112(2):666-70. PubMed ID: 8075886
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
